Abstract
The percentage of apoptotic cells among the tumor cells (apoptotic index) was determined in a series of 178 non-small cell lung carcinomas with a long term clinical follow-up by a terminal desoxynucleotidyl transferase mediated dUTP nick end labelling technique. In survival analysis, we found no statistically significant correlation between the apoptotic index and survival times. We estimated also the sensitivity of specimens to doxorubicin by a short term test. Tumors with a high apoptotic activity were more sensitive to doxorubicin than tumors with a less apoptotic index. Thus, our data indicate that apoptosis may be involved in drug response of lung tumors and it could be useful for the chemotherapeutic strategy to design drugs which trigger apoptosis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Riordan JR, Ling V. Genetic and biochemical characterization of multidrug resistance. Pharmacol Ther 1985; 28: 51–57.
Cole SPC, Bhardwaj G, Gerlach JH, et al. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 1992; 258: 1650–1654.
Batist G, Tulpule A, Sinha BK, Kathi AG, Meyers CE, Cowan KH. Overexpression of a novel anionic glutathione transferase in multidrug-resistant human breast cancer cells. J Biol Chem 1986; 261: 15544–15549.
Sinha BK, Dusre L, Collins C, Myers CE. Resistance of paraquat and adriamycin in human breast tumor cells: role of the free radical formation. Biochim Biophys Acta 1989; 1010: 304–310.
Kelley SL, Basu A, Teicher BA, Hacker MP, Hamer DH, Lazo JS. Overexpression of metallothionein confers resistance to anticancer drugs. Science 1988; 241: 1813–1815.
Ciocca DR, Fuqua SAW, Lock-Loim S, Toff DO, Welch WJ, McGuire WL. Response of human breast cancer cells to heat shock and chemotherapeutic drugs. Cancer Res 1992; 52: 3648- 3654.
Liu LF. DNA topoisomerase poisons as antitumor drugs. Annu Rev Biochem 1989; 58: 351–375.
Newman EM, Lu Y, Kashani-Sabet M, Kesavan V, Scanlon KJ. Mechanisms of cross-resistance to methotrexate and 5-fluorouracil in an A2780 human ovarian carcinoma cell subline resistant to cisplatin. Biochem Pharmacol 1988; 37: 443–447.
Futscher BW, Campbell K, Dalton WS. Collateral sensitivity to nitrosoureas in multidrug-resistant cells selected with verapamil. Cancer Res 1992; 52: 5013–5017.
Preisler HD, Venugopalis P. Regrowth resistance in cancer: why has it been largely ignored? Cell Prolif 1995; 28: 347–356.
Buja LM, Eigenbrodt ML, Eigenbrodt EH. Apoptosis and necrosis. Basic types and mechanisms of cell death. Arch Pathol Lab Med 1993, 117: 1208–1214.
Desoize B. Anticancer drug resistance and inhibition of apoptosis. Anticancer Res 1994; 14: 2291–2294.
Volm M, Wayss K, Kauffmann M, Mattern J. Pretherapeutic detection of tumour resistance and the results of tumour chemotherapy. Eur J Cancer 1979; 15: 983–993.
Volm M, Drings P, Mattern J, Sonka J, Vogt-Moykopf I, Wayss K. Prognostic significance of DNA patterns and resistance-predictive tests in non-small cell lung carcinoma. Cancer 1985; 56: 1396–1403.
Group for sensitivity testing of tumors (KSST) In vitro shortterm test to determine the resistance of human tumors to chemotherapy. Cancer 1981; 48: 2127–2135.
Volm M. Use of tritiated nucleotide incorporation for prediction of sensitivity of tumors to cytostatic agents. Behring Inst Mitt 1984; 74: 273–284.
Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Statistical Assoc 1958; 53: 457–481.
Ohmori T, Podack ER, Nihio K, et al. Apoptosis of lung cancer cells caused by some anti-cancer agents (MMC, CPT-11, ADM) is inhibited by BCL2. Biochem Biophys Res Comm 1993; 192: 30–36.
Segal-Bendirdjian E, Jacquemin-Sablon A. Cisplatin resistance in a murine leukemia cell line is associated with a defective apoptotic process. Exp Cell Res 1995; 218: 201–212.
Reed JC. Bcl2: Prevention of apoptosis as a mechanism of drug resistance. Hematol Oncol Clin North Am 1995; 9:451–473.
Volm M, Mattern J. Increased expression of Bcl-2 in drug-resistant squamous cell lung carcinomas. Int J Oncol 1995; 7: 1333–1338.
Ritke MK, Rusnak JM, Lazo JS, Allan WP, Dive C, Heer S, Yalowich JC. Differential induction of etoposide-mediated apoptosis in human leukemia HL-60 and K562 cells. Mol Pharmacol 1994; 46: 605–611.
Bhalla K, Huang Y, Tang C, et al. Characterization of a human myeloid leukemia cell line highly resistant to taxol. Leukemia 1994; 8: 465–475.
Keith FJ, Bradbury DA, Zhu YM, Russell NH. Inhibition of bcl2 with antisense oligonucleotides induces apoptosis and increases the sensitivity of AML blasts to Ara-C. Leukemia 1995; 9: 131–138.
Reed JC, Kitada S, Takayama S, Miyashita T. Regulation of chemoresistance by the bcl2 oncoprotein in non-Hodgkin's lymphoma and lymphocytic leukemia cell lines. Ann Oncol 1994; 5: 61–65.
Törmänen U, Eerola AK, Rainio P, et al. Enhanced apoptosis predicts shortened survival in non-small cell lung carcinoma. Cancer Res 1995; 55: 5595–5602.
Lipponen PK, Aaltomaa S. Apoptosis in bladder cancer as related to standard prognostic factors and prognosis. J Path 1994; 173: 333–339.
Levine EL, Renehan A, Gossiel R, et al. Apoptosis, intrinsic radiosensitivity and prediction of radiotherapy response in cervical carcinoma. Radiother Oncol 1995; 37: 1–9.
Lipponen P, Aaltomaa S, Kosma VM, Syrjänen K. Apoptosis in breast cancer as related to histopathological characteristics and prognosis. Eur J Cancer 1994; 30: 2068–2073.
Vesalainen S, Lipponen P, Talja M, Syrjänen K. Histological grade, perineural infiltration, tumour-infiltrating lymphocytes and apoptosis as determinants of long-term prognosis in prostatic adenocarcinoma. Eur J Cancer 1994; 30: 1797–1803.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Stammler, G., Volm, M. Apoptosis in non-small cell lung cancer as related to drug resistance and prognosis. Apoptosis 1, 95–99 (1996). https://doi.org/10.1007/BF00142084
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00142084